FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $4.48, $0.24 better than the analyst estimate of $4.24. Revenue for the quarter came in at $3 billion versus the consensus estimate of $2.93... More

